title: Intraoperative coronary thrombosis: can aprotinin be incriminated?
authors.forename: D
authors.initials: D
authors.lastname: Royston
mesh_terms: D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D001792:Blood Platelets / Q000187:drug effects; D001026:Coronary Artery Bypass; D003328:Coronary Thrombosis / Q000139:chemically induced*; D004730:Endothelium, Vascular / Q000187:drug effects; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005342:Fibrinolysis / Q000187:drug effects; D006083:Graft Occlusion, Vascular / Q000139:chemically induced; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced*; D009203:Myocardial Infarction / Q000139:chemically induced; D012307:Risk Factors; D012449:Safety; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D014656:Vascular Surgical Procedures; D014680:Veins / Q000637:transplantation
chemical_list: D015842:Serine Proteinase Inhibitors; D007611:Aprotinin; D005341:Fibrinolysin